people
  • Overview
  • Grant Central
    Find funding & collaboration opportunities, and coordinate proposal development.
  • Medvane
    View biomedical research & publication trends within the Harvard community.
  • Harvard Catalyst Profiles
    Contact, publication, and social network information about Harvard faculty and fellows.
  • Research Navigators
    Scientific liaisons who facilitate clinical and translational research.
learning
resources

Medvane

The present state and historical trends of biomedical research in the Harvard community.

Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet 1997

Neurosurgical Service, Massachusetts General Hospital, Charlestown 02129, USA.
Patients with multiple schwannomas without vestibular schwannomas have been postulated to compose a distinct subclass of neurofibromatosis (NF), termed "schwannomatosis." To compare the molecular-genetic basis of schwannomatosis with NF2, we examined the NF2 locus in 20 unrelated schwannomatosis patients and their affected relatives. Tumors from these patients frequently harbored typical truncating mutations of the NF2 gene and loss of heterozygosity of the surrounding region of chromosome 22. Surprisingly, unlike patients with NF2, no heterozygous NF2-gene changes were seen in normal tissues. Examination of multiple tumors from the same patient revealed that some schwannomatosis patients are somatic mosaics for NF2-gene changes. By contrast, other individuals, particularly those with a positive family history, appear to have an inherited predisposition to formation of tumors that carry somatic alterations of the NF2 gene. Further work is needed to define the pathogenetics of this unusual disease mechanism.
See PubMed record in a new window